PF-Atlas › Исследования › Liver Crossover
Исследования: Liver Crossover (46)
46 публикаций в теме «Liver Crossover», проиндексированных PF-Atlas из PubMed и мировых журналов.
Межзаболеваемые исследования. Эти работы относятся к смежным фибротическим, онкологическим или регенеративным областям и отслеживаются ради механистической значимости для ИЛФ. Они не являются прямым доказательством лечения идиопатического легочного фиброза.
- Metal Ion Nanosystems for Targeted siRNA Delivery and Coordinated Macrophage Polarization Modulation for Liver Fibrosis Reversal. · ACS applied materials & interfaces · 2026
- A Novel Anti-Fibrotic Role of G-Protein-Coupled Receptor 119 in Hepatic Stellate Cells. · Biomolecules & therapeutics · 2026
- [Anti-fibrotic effects of Prismatomeris tetrandra ethyl acetate fraction: chemical characterization, bioinformatics analysis, and in vivo validation]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2026
- Mechanisms and reversal strategies of liver fibrosis: from regulation of cell fate to clinical translation. · Journal of translational medicine · 2026
- Oleanolic acid alleviates hepatic fibrosis by inhibiting liver macrophage recruitment and polarization. · Molecular immunology · 2026
- Epigenetic regulation in liver fibrosis: Focus on the chromatin accessibility landscape. · European journal of pharmacology · 2026
- The m6A reader IGF2BP2 promotes hepatic fibrosis by stabilizing AEBP1 mRNA and regulating GRB2-mediated hepatic stellate cell activation. · Biochimica et biophysica acta. Molecular basis of disease · 2026
- HIF-1α-ASS1 axis drives reprogramming of arginine metabolism controls hepatic stellate cell activation in hepatic fibrosis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- DN203316, a novel PPARδ agonist, suppresses ferroptotic signaling and fibrogenesis in metabolic dysfunction-associated steatohepatitis. · Experimental & molecular medicine · 2026
- Compound Biejia-Ruangan tablets activate the STING-TBK1 pathway to alleviate hepatic fibrosis in alveolar echinococcosis. · Microbiology spectrum · 2026
- Targeted delivery of lupeol via hyaluronic acid-modified ZIF-8 for anti-hepatic fibrosis therapy. · Materials today. Bio · 2026
- Microtubule-Targeting Drugs Induce Mesenchymal-Epithelial Transition in Hepatic Stellate Cells. · Liver international : official journal of the International Association for the Study of the Liver · 2026
- Integrating Network Pharmacology and Experimental Validation to Elucidate the Role of Huaier in Attenuating Liver Fibrosis via the AKT Signalling Pathway. · Clinical and experimental medicine · 2026
- Total Flavonoids from Carthamus tinctorius L. Reduce Liver Fibrosis by Influencing Autophagy via Hedgehog Signaling. · International journal of molecular sciences · 2026
- Elucidating the therapeutic mechanisms of quercetin in hepatic fibrosis: an integrated metabolomic and transcriptomic analysis. · Frontiers in nutrition · 2026
- Licorice Total Flavonoids Alleviate Liver Fibrosis by Inhibiting the TGF-β1 Signaling Pathways. · Journal of visualized experiments : JoVE · 2026
- Vitamin a modulates neurogenesis-associated pathways and cholinergic signaling in Alzheimer's disease: potential role of reactive astrocytes via NGN2/SOX-11 and SIRT-1. · Scientific reports · 2026
- Ginsenosides alleviate the progression of hepatic fibrosis by targeting the liver circadian clock gene CLOCK. · Molecular medicine reports · 2026
- Bupleuri radix total saikosaponins alleviate liver fibrosis by inhibiting hepatic stellate cell activation via SIRT3-SMAD3/HIF-1α -mediated glycolysis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Potentially regulating the ApoB RNA editosome via FXR activation: The natural compound continentalic acid alleviates hepatic fibrogenesis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Discovery of cis-Gnetin H from peony seed coat as a potent antifibrotic agent modulating hepatic fibro-inflammatory pathways and gut microbiota homeostasis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Study of α-Amyrin targeting Sirt1/PGC-1α/PPARα axis to regulate fatty acid metabolism against liver fibrosis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Huaganjian decoction attenuates liver fibrosis via purine metabolic-inflammatory synergistic crosstalk: network pharmacology combined with multi-omics analyses. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Taraxasterol alleviates liver fibrosis by suppressing hepatic stellate cell activation via the HSD11B1-ERK MAPK signaling axis. · Acta biochimica et biophysica Sinica · 2026
- SLC25A1-targeted gene therapy attenuates liver fibrosis through NEDD4-mediated ubiquitination and degradation of PPARγ. · Pharmacological research · 2026
- 6-Shogaol attenuates liver fibrosis by driving hepatic stellate cell senescence through the cGAS-STING-NF-κB axis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Indole-3-carbaldehyde mitigates fibrosis progression in MASH with T2DM via the SIRT1/TGF-β/SMAD signaling pathway. · Biochimica et biophysica acta. Molecular basis of disease · 2026
- Loganin Ameliorates Cholestatic Liver Fibrosis by Inhibiting Hepatic Stellate Cell Autophagy and Activation Through EGFR Signaling. · Mediators of inflammation · 2026
- Integrated Multi-Omics Reveals BCAA Metabolic Remodeling Associated with the Antifibrotic Effects of Ku-Cai-Gao in Liver Fibrosis. · Current drug metabolism · 2026
- Morroniside ameliorates hepatic fibrosis in mice by targeting ACYP1 to promote NCOA4-mediated ferritinophagy and ferroptosis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Taohong Huazhuo decoction alleviates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting the nicotinamide adenine dinucleotide phosphate oxidase 4/nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 signaling pathway. · Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2026
- Copper overload drives hepatic stellate cell activation via cuproptosis to exacerbate acute liver injury in murine malaria. · Parasites & vectors · 2026
- The mitochondrial protein Timm13 promotes liver fibrosis by activating TGFβ signaling through Hsp90aa1. · Free radical biology & medicine · 2026
- A 3D bioengineered human liver for the study of acute and chronic drug-induced hepatotoxicity and fibrosis. · Frontiers in bioengineering and biotechnology · 2026
- Curcumin Targets Crispld2 to Suppress Hepatic Stellate Cell Activation via PI3K/AKT Pathway Inhibition in Hepatic Fibrosis. · Liver international : official journal of the International Association for the Study of the Liver · 2026
- Curcumol induces autophagy-dependent hepatic stellate cell death through methionine metabolism disruption. · Toxicology and applied pharmacology · 2026
- Low concentrations of sorafenib increase dihydrosphingomyelin during antifibrotic processes in human hepatic stellate cells. · Biochemical and biophysical research communications · 2026
- Fibroblast Growth Factor 21: Mechanisms, Therapeutic Potential, and Clinical Translation in Metabolic Dysfunction. · Drug design, development and therapy · 2026
- A thioacrylamide-based compound directly counteracts hepatic fibrosis with profound anti-obesity action. · JHEP reports : innovation in hepatology · 2026
- Paeoniflorin Ameliorates Liver Fibrosis by Inhibiting HIF-1α-Mediated Mitophagy in Hepatic Stellate Cells. · Phytotherapy research : PTR · 2026
- Precise delivery of medical gases by engineered nanomedicine for enhanced liver fibrosis therapy. · Materials today. Bio · 2026
- Resveratrol Alleviates Arsenic-Induced Liver Fibrosis in Rats by Correcting SIRT1-Mediated Disorder of Hepatic Bile Acid Metabolism. · International journal of molecular sciences · 2026
- Recent Advances in the Study of Traditional Chinese Medicine in Reversing Hepatic Fibrosis Through the Regulation of Hepatic Stellate Cells Apoptosis Pathways. · Drug design, development and therapy · 2026
- Qi Wei Zhi Gan formulation alleviates progressive fibrosis in metabolic dysfunction-associated steatohepatitis through suppressing Peroxidasin-collagen IV crosslinking. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Regression of liver cirrhosis. · Journal of hepatology · 2026
- Involvement of fibroblast-specific protein 1 and matrix metalloproteinase-13 in CCl4-induced reversible liver fibrosis. · Gene · 2016
Медицинская оговорка. Списки исследований приведены только для информации и не являются медицинской рекомендацией.